Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Valsartan in Postmenopausal Hypertensive Women
NCT03432468Unknown
- Sponsor
- Lanzhou University
- Start
- Apr 2018
- Primary completion
- Aug 2019
- Modality
- Small Molecules
01
Overview
Trial of valsartan in hypertension (HTN) (2 arms), sponsored by Lanzhou University. Primary endpoints: Left Ventricular Mass Index at 12 months, Ambulatory Blood Pressure Monitoring at 12 months and 1 more. Status: unknown.
02
Drugs
valsartan
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT03432468.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03432468.